The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone.
Panos Kanavos, PhD
Advertisement
Panos Kanavos, PhD, is professor in practice in international health policy in the Department of Health Policy at the London School of Economics and Political Science, deputy director at LSE Health, and director of the Medical Technology Research Group (MTRG).
Articles by Panos Kanavos, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
2
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5